Inventor profile of:

Philippe Moingeon

City:

Verrieres Le Buisson

Country:

France

Published Applications:

12

Last publication date:

2017-12-28

Top Assignees for applications by Philippe Moingeon

The entities that hold a legal rights for patent applications filed by inventor Moingeon Philippe:

Recent patent applications by Moingeon Philippe

Philippe Moingeon from Verrieres Le Buisson, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-12-28
US20170370946A1
Physics

Sialylated fetuin-A as a marker of immunotherapy efficacy

#2 | 2017-08-17
US20170233816A1
Chemistry; metallurgy

Markers of immune response

#3 | 2017-08-10
US20170224810A1
Human necessities

Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids

#4 | 2017-06-08
US20170157240A1
Human necessities

COMPOSITION OF ALLERGEN EXTRACTS HAVING REDUCED TOXICITY AND METHOD OF PRODUCTION THEREOF

#5 | 2016-12-22
US20160367631A1
Human necessities

C1q as a therapeutic agent of allergy and/or asthma

#6 | 2016-02-04
US20160032018A1
Chemistry; metallurgy

Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa

#7 | 2014-12-25
US20140377761A1
Chemistry; metallurgy

Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy

#8 | 2014-04-24
US20140112955A1
Physics

Biomarkers of immunotherapy efficacy

#9 | 2012-07-05
US20120171710A1
Physics

Method for grass species identification

#10 | 2012-07-05
US20120171198A1
Chemistry; metallurgy

Use of IgGimmunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route

#11 | 2012-06-14
US20120148626A1
Human necessities

Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids

#12 | 2011-12-01
US20110293665A1
Chemistry; metallurgy

Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes

InventorID:

736099